You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
晨光生物(300138.SZ)業績快報:2020年淨利升39.65%至2.7億元
格隆匯 02-26 20:10

格隆匯 2 月 26日丨晨光生物(300138.SZ)披露2020年度業績快報,報吿期實現營業收入39.34億元,同比增長20.49%;歸屬於上市公司股東的淨利潤2.7億元,同比增長39.65%;基本每股收益0.54元。

2020年,公司堅持以客户為中心,持續提升綜合競爭優勢。主導產品辣椒紅銷量7200多噸,同比增長約20%,連續十三年穩居世界第一;辣椒精銷量1000多噸,市場份額持續擴大;葉黃素產品銷量4.5億克,再上新台階,並通過預售模式,對平抑價格波動、維護行業健康發展起到了重要作用。營養藥用類產品發展勢頭良好,銷售收入突破2億元,番茄紅素、薑黃素等產品與國內外多家知名終端客户達成合作,進一步提高了晨光生物品牌影響力。花椒提取物產品銷量持續上升,成為公司又一個位居世界第一或前列的品種。甜菊糖銷售快速增長,實現收入6000多萬元;珍品油脂系列產品銷售實現新突破,銷售收入5200多萬;保健食品業務進一步開拓OEM模式、創新銷售途徑,實現銷售收入2400多萬元,同比增長140%以上。棉籽蛋白業務堅持原料採購和產品銷售對鎖經營模式,規避了行情帶來的風險。各產品銷售持續增長,營業利潤、利潤總額、基本每股收益分別同比增長53.23%、48.79%、42.11%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account